33.05
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
Earnings call transcript: Viking Therapeutics Q2 2025 sees increased R&D expenses - Investing.com
Is a relief rally coming for Viking Therapeutics Inc. holdersMarket Growth Summary & Verified Entry Point Signals - newser.com
What makes Viking Therapeutics Inc. stock attractive to growth fundsJuly 2025 News Drivers & Proven Capital Preservation Tips - newser.com
Live market analysis of Viking Therapeutics Inc.Chart Signals & Weekly High Return Stock Opportunities - newser.com
Using data models to predict Viking Therapeutics Inc. stock movementMarket Movement Recap & Free Technical Pattern Based Buy Signals - newser.com
How hedge fund analytics apply to Viking Therapeutics Inc. stock2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
Why Viking Therapeutics Inc. stock attracts high net worth investors2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Can Viking Therapeutics Inc. stock hit record highs againMarket Volume Summary & Real-Time Buy Zone Alerts - newser.com
Key metrics from Viking Therapeutics Inc.’s quarterly dataWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Can trapped investors hope for a rebound in Viking Therapeutics Inc.Exit Point & High Accuracy Buy Signal Tips - newser.com
Down 44%, Should You Buy the Dip on Viking Therapeutics? - The Motley Fool
How to build a custom watchlist for Viking Therapeutics Inc.Volume Spike & Risk Managed Trade Strategies - newser.com
Is Viking Therapeutics Inc. stock oversold or undervaluedQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
Viking Therapeutics Inc. stock volume spike explained2025 Market Sentiment & Community Driven Trade Alerts - newser.com
How to integrate Viking Therapeutics Inc. into portfolio analysis tools2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
VKTX stock tumbles 29% today — Viking Therapeutics weight-loss trial results fuel massive investor sell-off and market jitters - MSN
Viking Therapeutics, Inc. $VKTX Shares Acquired by Blair William & Co. IL - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Down 4.1%What's Next? - MarketBeat
Will a bounce in Viking Therapeutics Inc. offer an exitJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Sector ETF performance correlation with Viking Therapeutics Inc.2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Why Akero Therapeutics Stock Trounced the Market on Thursday - AOL.com
Wealth Enhancement Advisory Services LLC Purchases New Stake in Viking Therapeutics, Inc. $VKTX - MarketBeat
Analyzing Viking Therapeutics Inc. with risk reward ratio charts2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 8.1%Should You Buy? - MarketBeat
Why Shares in Viking Therapeutics Surged This Week - sharewise.com
Viking Therapeutics (VKTX) Shares Surge Amid Acquisition Activit - GuruFocus
Viking Therapeutics (VKTX) Rises Amid Akero Therapeutics Acquisi - GuruFocus
Viking, Genfit, Sagimet jump on Novo- Akero deal (AKRO:NASDAQ) - Seeking Alpha
Volume spikes in Viking Therapeutics Inc. stock – what they meanJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Visualizing Viking Therapeutics Inc. stock with heatmapsVolume Spike & Weekly High Momentum Picks - newser.com
Will Viking Therapeutics Inc. stock maintain momentum in 2025Trade Ideas & Growth Focused Entry Reports - newser.com
Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time. - MSN
Will Viking Therapeutics Inc. stock attract more institutional investorsJuly 2025 Rallies & Technical Pattern Alert System - newser.com
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Viking Therapeutics' (VKTX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know - sharewise.com
Viking Therapeutics (NASDAQ:VKTX) Trading Up 2.6%Here's Why - MarketBeat
Where is Viking Therapeutics (VKTX) Headed According to Analysts? - MSN
Viking Therapeutics (NASDAQ:VKTX) Shares Down 2.3%Here's Why - MarketBeat
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts - Stocktwits
Viking Therapeutics (NASDAQ:VKTX) Trading Up 8.6%Here's What Happened - MarketBeat
Why Viking Therapeutics (VKTX) Is Up 15.1% After Acquisition Buzz and Analyst Focus on Its Pipeline - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):